Planned, designed and managed 10 clinical trials across multiple regions.

Identify favourable partnerships with commercial and academic entities.

Expertise in the development of a variety of formulation types, including nasal powders and oral liquids.

Experienced team of scientists, pharmacists, engineers and regulatory experts who collectively cover the drug and device lifecycle.

Successfully licensed 3 products that collectively cover EMA, FDA and MHRA approval.

Performed non-clinical in vivo studies with peptide and vaccine formulations.